Literature DB >> 17823648

Haloperidol induces the nuclear translocation of phosphatidylinositol 3'-kinase to disrupt Akt phosphorylation in PC12 cells.

Yunxiu Dai1, Zelan Wei, Chantelle F Sephton, Di Zhang, Deborah H Anderson, Darrell D Mousseau.   

Abstract

OBJECTIVE: The antipsychotic drug haloperidol (HAL) has been linked to apoptosis and to inhibition of prosurvival Akt signalling in pheochromocytoma (PC12) and neuronal cell cultures. However, the mechanism involved is unclear.
METHODS: We used HAL to induce cytotoxicity in preneuronal PC12 cells. The expression and the subcellular localization of selected components of the PI3K-Akt survival cascade were monitored with standard biochemical approaches, such as subcellular fractionation, western blot analysis, gene transfer and fluorescence microscopy.
RESULTS: PC12 cell stimulation with the epidermal growth factor (used as a control) results in normal processing of phosphatidylinositol 3'-kinase (PI3K)-Akt signalling (e.g., localization of PI3K to the plasma membrane and phosphorylation of Akt (Ser473). Surprisingly, HAL induces PI3K-generated phosphoinositol [phosphatidylinositol-3,4,5-triphosphate (PIP3), which conflicts with its ability to inhibit Akt. In fact, the production of PIP3s is nuclear, as assessed by the localized concentration of a fluorophore-tagged PIP3-targeting pleckstrin homology protein and a fluorophore-tagged substrate-trapping mutant of the phosphoinositide phosphatase, phosphatase and tensin homologue deleted on chromosome 10 (PTEN). However, phosphoinositide-dependent protein kinase 1 (PDK1, the activating kinase of Akt) does not colocalize to the nucleus with the PI3K complex. This effectively inactivates both cytoplasmic and nuclear pools of Akt.
CONCLUSION: The differential compartmentalization of effectors of the PI3K-PDK1-Akt pathway is a unique means by which HAL disrupts Akt functioning in PC12 cells.

Entities:  

Keywords:  EGF; haloperidol; phospholipids

Mesh:

Substances:

Year:  2007        PMID: 17823648      PMCID: PMC1963350     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  40 in total

1.  Mechanisms underlying the protective potential of alpha-tocopherol (vitamin E) against haloperidol-associated neurotoxicity.

Authors:  Anke Post; Monika Rücker; Frauke Ohl; Manfred Uhr; Florian Holsboer; Osborne F X Almeida; Theologos M Michaelidis
Journal:  Neuropsychopharmacology       Date:  2002-03       Impact factor: 7.853

2.  The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.

Authors:  C J Wu; D M O'Rourke; G S Feng; G R Johnson; Q Wang; M I Greene
Journal:  Oncogene       Date:  2001-09-20       Impact factor: 9.867

3.  Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms.

Authors:  I Gil-ad; B Shtaif; R Shiloh; A Weizman
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

4.  Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase.

Authors:  B D Cuevas; Y Lu; M Mao; J Zhang; R LaPushin; K Siminovitch; G B Mills
Journal:  J Biol Chem       Date:  2001-05-03       Impact factor: 5.157

5.  Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB.

Authors:  Hugo Stocker; Mirjana Andjelkovic; Sean Oldham; Muriel Laffargue; Matthias P Wymann; Brian A Hemmings; Ernst Hafen
Journal:  Science       Date:  2002-02-28       Impact factor: 47.728

6.  ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase.

Authors:  Cheng Fang Yu; Zhen-Xiang Liu; Lloyd G Cantley
Journal:  J Biol Chem       Date:  2002-03-14       Impact factor: 5.157

7.  The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor.

Authors:  Or Gozani; Philip Karuman; David R Jones; Dmitri Ivanov; James Cha; Alexey A Lugovskoy; Cheryl L Baird; Hong Zhu; Seth J Field; Stephen L Lessnick; Jennifer Villasenor; Bharat Mehrotra; Jian Chen; Vikram R Rao; Joan S Brugge; Colin G Ferguson; Bernard Payrastre; David G Myszka; Lewis C Cantley; Gerhard Wagner; Nullin Divecha; Glenn D Prestwich; Junying Yuan
Journal:  Cell       Date:  2003-07-11       Impact factor: 41.582

8.  Nuclear translocation of 3'-phosphoinositide-dependent protein kinase 1 (PDK-1): a potential regulatory mechanism for PDK-1 function.

Authors:  Mei A Lim; Chintan K Kikani; Michael J Wick; Lily Q Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

9.  Gab1 is an integrator of cell death versus cell survival signals in oxidative stress.

Authors:  Marina Holgado-Madruga; Albert J Wong
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

10.  Atypical antipsychotics attenuate neurotoxicity of beta-amyloid(25-35) by modulating Bax and Bcl-X(l/s) expression and localization.

Authors:  Zelan Wei; Darrell D Mousseau; J Steven Richardson; Lillian E Dyck; Xin-Min Li
Journal:  J Neurosci Res       Date:  2003-12-15       Impact factor: 4.164

View more
  9 in total

1.  Inhibition of the PI3K pathway suppresses hormonal secretion and limits growth in pheochromocytoma cells.

Authors:  Joel T Adler; Daniel G Hottinger; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

2.  The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation.

Authors:  Sang Won Park; Yingjiang Zhou; Justin Lee; Allen Lu; Cheng Sun; Jason Chung; Kohjiro Ueki; Umut Ozcan
Journal:  Nat Med       Date:  2010-03-28       Impact factor: 53.440

3.  An (Immuno) Fluorescence Protocol for Monitoring Monoamine Oxidase A/B Protein Distribution Within the Cell.

Authors:  Tyler J Wenzel; Jennifer N K Nyarko; Ryan M Heistad; Paul R Pennington; Chris P Phenix; Darrell D Mousseau
Journal:  Methods Mol Biol       Date:  2023

4.  Enhanced phosphatidylinositol 3-kinase (PI3K)/Akt signaling has pleiotropic targets in hippocampal neurons exposed to iron-induced oxidative stress.

Authors:  Romina María Uranga; Sebastián Katz; Gabriela Alejandra Salvador
Journal:  J Biol Chem       Date:  2013-05-16       Impact factor: 5.157

Review 5.  Molecular mechanisms and clinical implications of reversible protein S-glutathionylation.

Authors:  John J Mieyal; Molly M Gallogly; Suparna Qanungo; Elizabeth A Sabens; Melissa D Shelton
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

Review 6.  Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action.

Authors:  Zachary Freyberg; Stephen J Ferrando; Jonathan A Javitch
Journal:  Am J Psychiatry       Date:  2009-11-16       Impact factor: 18.112

7.  The PI3K regulatory subunits p55α and p50α regulate cell death in vivo.

Authors:  S Pensa; K Neoh; H K Resemann; P A Kreuzaler; K Abell; N J Clarke; T Reinheckel; C R Kahn; C J Watson
Journal:  Cell Death Differ       Date:  2014-06-06       Impact factor: 15.828

8.  Neurodevelopment in schizophrenia: the role of the wnt pathways.

Authors:  Isabella Panaccione; Flavia Napoletano; Alberto Maria Forte; Giorgio D Kotzalidis; Antonio Del Casale; Chiara Rapinesi; Chiara Brugnoli; Daniele Serata; Federica Caccia; Ilaria Cuomo; Elisa Ambrosi; Alessio Simonetti; Valeria Savoja; Lavinia De Chiara; Emanuela Danese; Giovanni Manfredi; Delfina Janiri; Marta Motolese; Ferdinando Nicoletti; Paolo Girardi; Gabriele Sani
Journal:  Curr Neuropharmacol       Date:  2013-09       Impact factor: 7.363

9.  The wnt pathway in mood disorders.

Authors:  Gabriele Sani; Flavia Napoletano; Alberto Maria Forte; Giorgio D Kotzalidis; Isabella Panaccione; Giulio Maria Porfiri; Alessio Simonetti; Matteo Caloro; Nicoletta Girardi; Carla Ludovica Telesforo; Giulia Serra; Silvia Romano; Giovanni Manfredi; Valeria Savoja; Stefano Maria Tamorri; Alexia E Koukopoulos; Daniele Serata; Chiara Rapinesi; Antonio Del Casale; Ferdinando Nicoletti; Paolo Girardi
Journal:  Curr Neuropharmacol       Date:  2012-09       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.